Details of Drug-Drug Interaction
| Drug General Information (ID: DDIT743SU2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Calcipotriol (topical) | Drug Info | Abaloparatide | Drug Info | |||||
| Drug Type | Small molecule | Hormones | |||||||
| Therapeutic Class | Antipsoriatic Agents | Hormone Modulators | |||||||
| Structure | |||||||||
| Mechanism of Calcipotriol (topical)-Abaloparatide Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased risk of hypercalcemia Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Calcipotriol (topical) | Abaloparatide | |||||||
| Mechanism | Hypercalcemia | Hypercalcemia | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Hypercalcemia | ||||||||
| Factor Description | Hypercalcemia is a condition in which the calcium level in your blood is above normal. Too much calcium in your blood can weaken your bones, create kidney stones, and interfere with how your heart and brain work. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Calcium and vitamin D status should be monitored closely when topical vitamin D analogs are used in combination with systemic vitamin D products or other agents that can increase serum calcium levels. | ||||||||